1 year return (CAGR)
26.99%
Fennec Pharmaceuticals Inc Exchange (NASDAQ, USD)
FENC
11.01
+0.10 (+0.92%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
11.56%
5 year return (CAGR)
6.02%
10 year return (CAGR)
20.83%
Objective Corporation Stock Analysis – State Within State
Read MoreMarketcap
386.09M
Price/Sales
6.52
Ent value
378.15M
Price/Book
9.10
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
11.57
EPS growth
-14.00%
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 11.00 |
| Daily high | 11.31 |
| Daily low | 10.85 |
| Daily Volume | 92K |
| All-time high | 118.80 |
| 1y analyst estimate | 17.67 |
| Beta | 1.10 |
| EPS (TTM) | -0.09 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | 1 Apr 2026 |
Downside potential
Loading...
Downside potential data
| FENC | S&P500 | |
| Current price drop from All-time high | -90.73% | -0.58% |
| Highest price drop | -99.76% | -56.47% |
| Date of highest drop | 27 Nov 2015 | 9 Mar 2009 |
| Avg drop from high | -89.64% | -10.68% |
| Avg time to new high | 1227 days | 12 days |
| Max time to new high | 4902 days | 1805 days |
News
